A systematic review of oral retinoids for treatment of acneiform eruptions induced by epidermal growth factor receptor inhibitors

Properties of FDA-approved small molecule protein kinase inhibitors: a 2021 update

(2021) Robert Roskoski   PHARMACOLOGICAL RESEARCH

Incidence of Adverse Cutaneous Reactions to Epidermal Growth Factor Receptor Inhibitors in Patients with Non-Small-Cell Lung Cancer

(2021) Paolo Gisondi et al.   DERMATOLOGY

The Impact of Long-Term Antibiotic Therapy of Cutaneous Adverse Reactions to EGFR Inhibitors in Colorectal Cancer Patients

(2021) Mara Mădălina Mihai et al.   Journal of Clinical Medicine

Pembrolizumab-induced follicular eruption and response to isotretinoin

(2021) Cathal O'Connor et al.   Immunotherapy

Optimizing Isotretinoin Treatment of Acne: Update on Current Recommendations for Monitoring, Dosing, Safety, Adverse Effects, Compliance, and Outcomes

(2020) Megan N. Landis   AMERICAN JOURNAL OF CLINICAL DERMATOLOGY

Management of dermatologic adverse events from cancer therapies: recommendations of an expert panel

(2020) Jade Cury-Martins et al.   ANAIS BRASILEIROS DE DERMATOLOGIA

Choosing Between Isotretinoin and Acitretin for Epidermal Growth Factor Receptor Inhibitor and Small Molecule Tyrosine Kinase Inhibitor Acneiform Eruptions

(2020) Collin M. Costello et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Prevention and management of dermatological toxicities related to anticancer agents: ESMO Clinical Practice Guidelines☆

(2020) M.E. Lacouture et al.   ANNALS OF ONCOLOGY

A Retrospective Chart Review on Oral Retinoids as a Treatment for Epidermal Growth Factor Receptor Inhibitor and Mitogen-activated Protein Kinase Kinase Inhibitor Induced Acneiform Eruptions

(2019) Elizabeth D. Andrews et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Dermatologic Toxicity Occurring During Anti-EGFR Monoclonal Inhibitor Therapy in Patients With Metastatic Colorectal Cancer: A Systematic Review

(2018) Mario E. Lacouture et al.   Clinical Colorectal Cancer

Non–Small Cell Lung Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology

(2017) David S. Ettinger et al.   Journal of the National Comprehensive Cancer Network

Management of egfr tki–induced dermatologic adverse events

(2015) B. Melosky et al.   Current Oncology

Isotretinoin for high-grade or refractory epidermal growth factor receptor inhibitor-related acneiform papulopustular eruptions

(2013) Herbert C. Chiang et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Supportive care treatments for toxicities of anti-EGFR and other targeted agents

(2012) B. Melosky   Current Oncology

Escalating therapy of cutaneous side effects of EGFR inhibitors: experience of German reference centers

(2012) Bernhard Homey et al.   JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT

Managing treatment-related adverse events associated with egfr tyrosine kinase inhibitors in advanced non-small-cell lung cancer

(2011) V. Hirsh   Current Oncology

The risk of nail changes with epidermal growth factor receptor inhibitors: A systematic review of the literature and meta-analysis

(2011) Benjamin C. Garden et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Management of Skin Toxicity Associated with Cetuximab Treatment in Combination with Chemotherapy or Radiotherapy

(2011) C. Pinto et al.   ONCOLOGIST

Clinical practice guidelines for the prevention and treatment of EGFR inhibitor-associated dermatologic toxicities

(2011) Mario E. Lacouture et al.   SUPPORTIVE CARE IN CANCER

Mortality in the Randomized, Controlled Lung Intergroup Trial of Isotretinoin

(2010) J. J. Lee et al.   Cancer Prevention Research

Randomized Phase II Trial of All-Trans-Retinoic Acid With Chemotherapy Based on Paclitaxel and Cisplatin As First-Line Treatment in Patients With Advanced Non–Small-Cell Lung Cancer

(2010) Oscar Arrieta et al.   JOURNAL OF CLINICAL ONCOLOGY

Isotretinoin Plus Clindamycin Seem Highly Effective Against Severe Erlotinib-Induced Skin Rash in Advanced Non-small Cell Lung Cancer

(2010) Paolo Bidoli et al.   Journal of Thoracic Oncology

Clinical Significance of Skin Toxicity due to EGFR-Targeted Therapies

(2009) Monica Giovannini et al.   Journal of Oncology

Cetuximab-induced Acneiform Eruption and the Response to Isotretinoin

(2008) P Vezzoli et al.   ACTA DERMATO-VENEREOLOGICA

Acitretin for Treatment of EGFR Inhibitor–Induced Cutaneous Toxic Effects

(2008) Rebecca G. Pomerantz et al.   ARCHIVES OF DERMATOLOGY